159 related articles for article (PubMed ID: 27015168)
21. HSP65-PRA identification of non-tuberculosis mycobacteria from 4892 samples suspicious for mycobacterial infections.
Saifi M; Jabbarzadeh E; Bahrmand AR; Karimi A; Pourazar S; Fateh A; Masoumi M; Vahidi E
Clin Microbiol Infect; 2013 Aug; 19(8):723-8. PubMed ID: 22963505
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary infection and colonization with nontuberculous mycobacteria, Taiwan, 2000-2012.
Chien JY; Lai CC; Sheng WH; Yu CJ; Hsueh PR
Emerg Infect Dis; 2014 Aug; 20(8):1382-5. PubMed ID: 25062534
[TBL] [Abstract][Full Text] [Related]
23. Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.
Ndung'u PW; Kariuki S; Ng'ang'a Z; Revathi G
J Infect Dev Ctries; 2012 Jan; 6(1):33-9. PubMed ID: 22240426
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting
Shin S; Yoo IY; Shim HJ; Kang OK; Jhun BW; Koh WJ; Huh HJ; Lee NY
Ann Lab Med; 2020 Mar; 40(2):169-173. PubMed ID: 31650734
[TBL] [Abstract][Full Text] [Related]
25. Interrelational changes in the epidemiology and clinical features of nontuberculous mycobacterial pulmonary disease and tuberculosis in a referral hospital in Japan.
Furuuchi K; Morimoto K; Yoshiyama T; Tanaka Y; Fujiwara K; Okumura M; Izumi K; Shiraishi Y; Mitarai S; Ogata H; Kurashima A; Yoshimori K; Ohta K; Goto H; Sasaki Y
Respir Med; 2019 Jun; 152():74-80. PubMed ID: 31128614
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999.
Djuretic T; Herbert J; Drobniewski F; Yates M; Smith EG; Magee JG; Williams R; Flanagan P; Watt B; Rayner A; Crowe M; Chadwick MV; Middleton AM; Watson JM
Thorax; 2002 Jun; 57(6):477-82. PubMed ID: 12037221
[TBL] [Abstract][Full Text] [Related]
27. A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.
Forson A; Kwara A; Kudzawu S; Omari M; Otu J; Gehre F; de Jong B; Antonio M
BMC Infect Dis; 2018 Apr; 18(1):149. PubMed ID: 29606091
[TBL] [Abstract][Full Text] [Related]
28. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan.
Liu CE; Chen C-; Hsiao JH; Young TG; Tsay RW; Fung CP
J Microbiol Immunol Infect; 2004 Oct; 37(5):295-300. PubMed ID: 15497011
[TBL] [Abstract][Full Text] [Related]
29. Higher-than-expected prevalence of non-tuberculous mycobacteria in HIV setting in Botswana: Implications for diagnostic algorithms using Xpert MTB/RIF assay.
Agizew T; Basotli J; Alexander H; Boyd R; Letsibogo G; Auld A; Nyirenda S; Tedla Z; Mathoma A; Mathebula U; Pals S; Date A; Finlay A
PLoS One; 2017; 12(12):e0189981. PubMed ID: 29272273
[TBL] [Abstract][Full Text] [Related]
30. Development of a One-Step Multiplex PCR Assay for Differential Detection of Major Mycobacterium Species.
Chae H; Han SJ; Kim SY; Ki CS; Huh HJ; Yong D; Koh WJ; Shin SJ
J Clin Microbiol; 2017 Sep; 55(9):2736-2751. PubMed ID: 28659320
[TBL] [Abstract][Full Text] [Related]
31. Changing Incidence and Characteristics of Nontuberculous Mycobacterial Infections in Scotland and Comparison With
Jarchow-MacDonald A; Smith M; Seagar AL; Russell CD; Claxton P; Laurenson IF; Moncayo-Nieto OL
Open Forum Infect Dis; 2023 Jan; 10(1):ofac665. PubMed ID: 36726549
[TBL] [Abstract][Full Text] [Related]
32. Utility of MPT64 antigen test for differentiating mycobacteria: Can correlation with liquid culture smear morphology add further value?
Nerurkar V; Kattungal S; Bhatia S
Indian J Pathol Microbiol; 2016; 59(2):185-7. PubMed ID: 27166037
[TBL] [Abstract][Full Text] [Related]
33. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
[TBL] [Abstract][Full Text] [Related]
34. Species diversity of non-tuberculous mycobacteria isolated from humans, livestock and wildlife in the Serengeti ecosystem, Tanzania.
Katale BZ; Mbugi EV; Botha L; Keyyu JD; Kendall S; Dockrell HM; Michel AL; Kazwala RR; Rweyemamu MM; van Helden P; Matee MI
BMC Infect Dis; 2014 Nov; 14():616. PubMed ID: 25403612
[TBL] [Abstract][Full Text] [Related]
35. Highlight on advances in nontuberculous mycobacterial disease in North America.
Mirsaeidi M; Farshidpour M; Allen MB; Ebrahimi G; Falkinham JO
Biomed Res Int; 2014; 2014():919474. PubMed ID: 25574470
[TBL] [Abstract][Full Text] [Related]
36. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey.
O'Brien RJ; Geiter LJ; Snider DE
Am Rev Respir Dis; 1987 May; 135(5):1007-14. PubMed ID: 3579001
[TBL] [Abstract][Full Text] [Related]
37. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
38. Multi-drug resistant tuberculosis in Northern Pakistan.
Butt T; Ahmad RN; Kazmi SY; Rafi N
J Pak Med Assoc; 2004 Sep; 54(9):469-72. PubMed ID: 15518370
[TBL] [Abstract][Full Text] [Related]
39. Isolation of non-tuberculous mycobacteria among patients with pulmonary tuberculosis in Ontario, Canada.
Damaraju D; Jamieson F; Chedore P; Marras TK
Int J Tuberc Lung Dis; 2013 May; 17(5):676-81. PubMed ID: 23575335
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium tuberculosis Complex Drug Resistance in a High Tuberculosis Incidence Area from the WHO Eastern Mediterranean Region.
Mansoori N; Douraghi M; Rajabloo AA; Taziki M; Yaseri M; Vaziri F
J Pharm Pharm Sci; 2017; 20(1):428-434. PubMed ID: 29197427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
